» Articles » PMID: 35413154

Efficacy of Melatonin in Term Neonatal Models of Perinatal Hypoxia-ischaemia

Overview
Specialty Neurology
Date 2022 Apr 12
PMID 35413154
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Neonatal encephalopathy (NE) is an important cause of mortality and disability worldwide. Therapeutic hypothermia (HT) is an effective therapy, however not all babies benefit. Novel agents are urgently needed to improve outcomes. Melatonin in preclinical studies has promising neuroprotective properties. This meta-analysis assessed the efficacy of melatonin in term animal models of NE on cerebral infarct size, neurobehavioural tests and cell death.

Methods: A literature search was carried out using Embase, MEDLINE and Web of Science (31 May 2021). We identified 14 studies and performed a meta-analysis with a random effects model using standardised mean difference (SMD) as the effect size. The risk of bias was assessed using the Systematic Review Centre for Laboratory animal Experimentation tool and publication bias was assessed with funnel plots, and adjusted using trim and fill analysis. Subgroup and meta-regression analyses were performed to assess the effects of study design variables.

Results: We observed significant reduction in brain infarct size (SMD -2.05, 95% CI [-2.93, -1.16]), improved neurobehavioural outcomes (SMD -0.86, 95% CI [-1.23, -0.53]) and reduction in cell death (SMD -0.60, 95% CI [-1.06, -0.14]) favouring treatment with melatonin. Neuroprotection was evident as a single therapy and combined with HT. Subgroup analysis showed greater efficacy with melatonin given before or immediately after injury and with ethanol excipients. The overall effect size remained robust even after adjustment for publication bias.

Interpretation: These studies demonstrate a significant neuroprotective efficacy of melatonin in term neonatal models of hypoxia-ischaemia, and suggest melatonin is a strong candidate for translation to clinical trials in babies with moderate-severe NE.

Citing Articles

Melatonin: a positive influencer of inflammation in neonatal encephalopathy.

Pang R, Molloy E, Robertson N Pediatr Res. 2025; .

PMID: 39833346 DOI: 10.1038/s41390-025-03876-7.


Neuroprotective Effect of Melatonin in a Neonatal Hypoxia-Ischemia Rat Model Is Regulated by the AMPK/mTOR Pathway.

Nacarkucuk E, Bernis M, Bremer A, Grzelak K, Zweyer M, Maes E J Am Heart Assoc. 2024; 13(19):e036054.

PMID: 39319465 PMC: 11681444. DOI: 10.1161/JAHA.124.036054.


Hypoxic-Ischemic Encephalopathy: Pathogenesis and Promising Therapies.

Yang M, Wang K, Liu B, Shen Y, Liu G Mol Neurobiol. 2024; 62(2):2105-2122.

PMID: 39073530 DOI: 10.1007/s12035-024-04398-9.


Neuroprotective effects of maternal melatonin administration in early-onset placental insufficiency and fetal growth restriction.

Malhotra A, Rocha A, Yawno T, Sutherland A, Allison B, Nitsos I Pediatr Res. 2024; 95(6):1510-1518.

PMID: 38225450 PMC: 11126390. DOI: 10.1038/s41390-024-03027-4.


[Research research on the use of melatonin in combination with therapeutic hypothermia for the treatment of neonatal hypoxic-ischemic encephalopathy].

Liu Y, Xia S Zhongguo Dang Dai Er Ke Za Zhi. 2023; 25(8):864-869.

PMID: 37668036 PMC: 10484075. DOI: 10.7499/j.issn.1008-8830.2302099.


References
1.
Eklind S, Mallard C, Arvidsson P, Hagberg H . Lipopolysaccharide induces both a primary and a secondary phase of sensitization in the developing rat brain. Pediatr Res. 2005; 58(1):112-6. DOI: 10.1203/01.PDR.0000163513.03619.8D. View

2.
Pang R, Avdic-Belltheus A, Meehan C, Martinello K, Mutshiya T, Yang Q . Melatonin and/or erythropoietin combined with hypothermia in a piglet model of perinatal asphyxia. Brain Commun. 2021; 3(1):fcaa211. PMC: 7876304. DOI: 10.1093/braincomms/fcaa211. View

3.
Kochanski R, Peng C, Higashida T, Geng X, Huttemann M, Guthikonda M . Neuroprotection conferred by post-ischemia ethanol therapy in experimental stroke: an inhibitory effect on hyperglycolysis and NADPH oxidase activation. J Neurochem. 2013; 126(1):113-21. DOI: 10.1111/jnc.12169. View

4.
Martinello K, Meehan C, Avdic-Belltheus A, Lingam I, Ragab S, Hristova M . Acute LPS sensitization and continuous infusion exacerbates hypoxic brain injury in a piglet model of neonatal encephalopathy. Sci Rep. 2019; 9(1):10184. PMC: 6629658. DOI: 10.1038/s41598-019-46488-y. View

5.
Ozyener F, Cetinkaya M, Alkan T, Goren B, Kafa I, Kurt M . Neuroprotective effects of melatonin administered alone or in combination with topiramate in neonatal hypoxic-ischemic rat model. Restor Neurol Neurosci. 2012; 30(5):435-44. DOI: 10.3233/RNN-2012-120217. View